Get started
Author

Chunai Wu

Observed name: Chun-ai Wu
ORCID: 0009-0007-1237-0841
Observed ORCID: 0009-0007-1237-0841
OpenAlex ID: A5068926590
Structural insights into the molecular mechanism of Escherichia coli SdiA, a quorum-sensing receptor
2014 · Truc Kim, Thao Duong, et al. · Acta Crystallographica Section D Biological Crystallography · 68
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1
2024 · Young-Seung Kim, Seung-Hoon Lee, et al. · Journal for ImmunoTherapy of Cancer · 10
PDF
Crystallization and preliminary X-ray studies of SdiA fromEscherichia coli
2007 · Chunai Wu, Neratur K. Lokanath, et al. · Acta Crystallographica Section F Structural Biology and Crystallization Communications · 6
PDF
Abstract 7722: Biomarkers of nelmastobart efficacy: BTN1A1 expression and tumor microenvironment dynamics in colorectal cancer
2026 · Bong-Ki Hong, Soohyeon Lee, et al. · Cancer Research
Abstract 6555: BTN1A1 blockade with Nelmastobart potentiates cisplatin-induced tumor suppression in NSCLC
2026 · Seung-Hoon Lee, Jong-Su Park, et al. · Cancer Research
410 BTN1A1 blockade enhances chemotherapy-induced anti-tumor immunity in preclinical lung cancer models
2025 · Seung-Hoon Lee, Young-Seung Kim, et al. · Journal for ImmunoTherapy of Cancer
PDF
83 BTN1A1 expression is inversely associated with CD8 + T cell infiltration in the tumor microenvironment of lung and colon cancer
2025 · Bong-Ki Hong, Young-Seung Kim, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract LB405: BTN1A1 and YAP1 expression as biomarkers in colon cancer: Phase 1b trial results of hSTC810
2025 · Bong-Ki Hong, Seung-Hoon Lee, et al. · Cancer Research
Abstract LB035: BTN1A1 and YAP1 crosstalk: A key mechanism in tumor immune evasion and therapeutic targeting
2025 · Seung-Hoon Lee, Chunai Wu, et al. · Cancer Research
BTN1A1 expression in colon cancer: Implications for immunotherapy and patient stratification.
2025 · Stephen S. Yoo, Bong-Ki Hong, et al. · Journal of Clinical Oncology
111 Spatial biology insights into simultaneous targeting of BTN1A1 and YAP in cancer: enhanced efficacy in 3D cultures and mouse models
2024 · Seung-Hoon Lee, Bong-Ki Hong, et al. · Journal for ImmunoTherapy of Cancer
499 Development and efficacy of a bispecific antibody targeting BTN1A1 and PD-L1 in cancer immunotherapy
2024 · Young-Seung Kim, Seung-Hoon Lee, et al. · Journal for ImmunoTherapy of Cancer
Abstract 1372: BTN1A1 regulates T cell-mediated cancer immunotherapy by interacting with Galectin-9, PD-1, and TIM3
2024 · Seung Hoon Lee, Young-Seung Kim, et al. · Cancer Research
573 BTN1A1-Targeted Immunotherapy Combined with Standard Therapy in Small Cell Lung Cancer (SCLC) and Colorectal Cancer
2023 · Stephen S Yoo, Soohyeon Lee, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract LBA019: The immune checkpoint protein BTN1A1 suppresses T cell activation through interactions with Gal9 and PD-1
2021 · Ezra M Chung, Young-Seung Kim, et al. · Molecular Cancer Therapeutics
Works count: 15
Citation count: 84
H-index: 3
I10-index: 2
Year
Topic
Type